Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Jun 15;10(12):1888-9.
doi: 10.4161/cc.10.12.15620. Epub 2011 Jun 15.

Vitamin D: a new player in the world of mTOR signaling

Editorial

Vitamin D: a new player in the world of mTOR signaling

Thomas S Lisse et al. Cell Cycle. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Vitamin D and the inhibition of mTOR signaling. Schematic representation showing signaling via mTORC1 (black arrows) and the targets for mTOR inhibitors (red arrows), including the active form of vitamin D, 1,25(OH)2D. mTORC1 integrates responses to various cell stimuli, leading to eventual phosphorylation of eukaryotic translation-initiation factor 4E-binding protein (4EBP) and p70S6 kinase 1 (p70S6K) and to promotion of mRNA translation, ribosomal biogenesis and the suppression of autophagy. DDIT4 (DNA-damage-inducible transcript 4, also known as REDD1) facilitates the assembly and activation of the tuberous sclerosis complex (TSC)1/2 complex for eventual suppression of downstream mTOR activity through actions on ras homolog enriched in the brain (Rheb). DDIT4 mRNA and protein is upregulated by 1,25(OH)2D treatment resulting in reduced phosphorylation of S6K1 and decreased cell proliferation and growth. Other abbreviations: PIP2, phosphatidylinositol-bisphosphate 2; PIP3, phosphatidylinositol-triphosphate; PTEN, phosphatase and tensin homolog; Akt, protein kinase B; mLST8, mTOR, Raptor, LST8 homolog; PRAS40, proline-rich Akt substrate 40 kDa; DEPTOR, DEP domain-containing mTOR-interacting protein.

References

    1. Plum LA, et al. Nat Rev Drug Discov. 2010;9:941–955. - PubMed
    1. Lisse TS, et al. FASEB J. 2011;25:937–947. - PMC - PubMed
    1. Zoncu R, et al. Nat Rev Mol Cell Biol. 2011;12:21–35. - PMC - PubMed
    1. Bai X, et al. Science. 2007;318:977–980. - PubMed
    1. Ellisen LW. Cell Cycle. 2005;4:1500–1502. - PubMed

Publication types

MeSH terms